相关实验视频

Updated: Jun 6, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

探索Panlongqi Tablet (PLQT) 对RA的分子机制:综合网络药理学,分子对接和实验验证

Huixin Song¹, Jinjin Yu¹, Yajie Yang¹

¹School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China.

International immunopharmacology

|December 1, 2024

概括

潘隆基片 (PLQT) 通过调节炎症和免疫反应,有效治疗类风湿性关节炎 (RA). 这项研究确定了关键活性化合物及其机制,支持PLQT.

科学领域:

综合医学是一个整体的医学.
药理学药理学是指药理学的学科.
类风湿病学类风湿病学

背景情况:

潘龙奇药片 (PLQT) 是一种用于治疗类风湿性关节炎 (RA) 的传统中医药.
它的治疗效果是公认的,但分子机制仍然不清楚.
PLQT被列入中国医疗保险名单.

研究的目的:

为了确定PLQT中的活性成分.
阐明PLQT在治疗RA中的分子机制.
为PLQT在RA的临床使用提供理论基础.

主要方法:

建立了完整的弗洛恩德辅助剂 (CFA) 诱导的RA等级模型.
利用网络药理学和分子对接来识别活性化合物和标.
进行了体外和体外实验以验证机制.

主要成果:

PLQT在治疗CFA诱导的关节炎方面表现出有效性,没有显著的副作用.
关键的活性成分包括黄类药物,比斯库马林衍生物,类药物和类药物.
机制包括调节炎症反应 (M1巨细胞),T淋巴细胞,血管新生,骨质细胞分化和自.

结论:

这项研究成功地阐明了PLQT对抗RA的活性成分和分子机制.
结果整合了网络药理学,分子对接和实验验证.
为PLQT在RA治疗中的临床应用提供了全面的理论基础.

关键词:

网络药理学网络药理学潘龙奇 (Panlongqi) 是一种长时间的药片.RAW264.7 大细胞类风湿性关节炎类风湿性关节炎类风湿性关节炎综合性血管生成 (Synovial angiogenesis) 是一种新生血管的形成.的T淋巴细胞.

更多相关视频

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...